Scott Braunstein
Insider
First SEC filing: July 22, 2021 · Latest: July 22, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | CRBU | A | 45,000 | · | · | 45,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 4, 2025 | ATAI | A | 56,818 | · | · | 56,818 Direct | · | Acquired | |
| June 26, 2025 | ATAI | A | 103,000 | · | · | 103,000 Direct | · | Acquired | |
| Feb. 20, 2025 | CRBU | A | 40,500 | · | · | 40,500 Direct | · | Acquired | (price as of 2026-10-05) |
| June 13, 2024 | ATAI | A | 206,000 | · | · | 206,000 Direct | · | Acquired | |
| Feb. 20, 2024 | CRBU | A | 39,500 | · | · | 39,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 21, 2023 | CRBU | A | 21,500 | · | · | 21,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 20, 2021 | CRBU | A | 27,500 | · | · | 27,500 Direct | · | Acquired | (price as of 2026-10-05) |
| June 9, 2020 | TARA | A | 9,000 | · | · | 9,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 10, 2020 | TARA | A | 26,500 | · | · | 26,500 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 15,641 | · | · | 15,641 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 16,214 | · | · | 16,214 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 2,861 | · | · | 2,861 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 15,737 | · | · | 15,737 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 6,676 | · | · | 6,676 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 9,537 | · | · | 9,537 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 2,861 | · | · | 2,861 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 9, 2020 | TARA | A | 9,537 | · | · | 9,537 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2019 | TCRT | A | 31,780 | · | · | 31,780 Direct | · | Acquired | (price as of 2026-10-05) |
| May 29, 2019 | ESPR | A | 4,967 | · | · | 5,019 Direct | +9551.92% | Acquired | |
| Dec. 31, 2018 | TCRT | A | 126,700 | · | · | 126,700 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 18, 2018 | TCRT | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 23, 2018 | ESPR | A | 10,100 | · | · | 10,100 Direct | · | Acquired | |
| Jan. 3, 2018 | PCRX | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 14, 2017 | PCRX | A | 22,000 | · | · | 22,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 14, 2017 | PCRX | A | 11,000 | · | · | 20,982 Direct | +110.20% | Acquired | (price as of 2026-10-05) |
| June 5, 2017 | PCRX | S | 768 | $43.32 | $33,270 | 9,982 Direct | -7.14% | Disposed | -42.2% (price as of 2026-10-05) |
| June 2, 2017 | PCRX | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-05) |
| April 17, 2017 | ESPR | A | 14,000 | · | · | 14,000 Direct | · | Acquired | |
| Dec. 7, 2016 | PCRX | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 15, 2016 | PCRX | A | 17,500 | · | · | 17,500 Direct | · | Acquired | (price as of 2026-10-05) |
| June 15, 2016 | PCRX | A | 8,750 | · | · | 10,750 Direct | +437.50% | Acquired | (price as of 2026-10-05) |
| June 9, 2016 | ESPR | A | 8,000 | · | · | 8,000 Direct | · | Acquired | |
| Jan. 29, 2016 | PCRX | P | 2,000 | $58.92 | $117,840 | 2,000 Direct | · | Acquired | -57.5% (price as of 2026-10-05) |
| Aug. 19, 2015 | ESPR | A | 20,000 | · | · | 20,000 Direct | · | Acquired | |
| July 13, 2015 | PCRX | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | CRBU | Option to purchase Common Stock | Common Stock | $1.80 | Feb. 19, 2036 | 45,000 | Acquired |
| Nov. 4, 2025 | ATAI | Stock Option | Common Shares | $5.28 | Nov. 4, 2035 | 56,818 | Acquired |
| June 26, 2025 | ATAI | Stock Option | Common Shares | $2.25 | June 26, 2035 | 103,000 | Acquired |
| Feb. 20, 2025 | CRBU | Option to purchase Common Stock | Common Stock | $1.41 | Feb. 19, 2035 | 40,500 | Acquired |
| June 13, 2024 | ATAI | Stock Option | Common Shares | $1.34 | June 13, 2034 | 206,000 | Acquired |
| Feb. 20, 2024 | CRBU | Option to purchase Common Stock | Common Stock | $6.81 | Feb. 19, 2034 | 39,500 | Acquired |
| Feb. 21, 2023 | CRBU | Option to purchase Common Stock | Common Stock | $6.12 | Feb. 20, 2033 | 21,500 | Acquired |
| Dec. 20, 2021 | CRBU | Option to purchase Common Stock | Common Stock | $15.16 | Dec. 19, 2031 | 27,500 | Acquired |
| June 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $35.00 | June 8, 2030 | 9,000 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | April 28, 2029 | 15,641 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | Dec. 3, 2028 | 16,214 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | July 11, 2028 | 2,861 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | April 28, 2029 | 15,737 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | Dec. 31, 2028 | 6,676 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | Dec. 31, 2028 | 9,537 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | July 11, 2028 | 2,861 | Acquired |
| Jan. 9, 2020 | TARA | Stock Option (Right to Buy) | Common Stock | $9.18 | May 24, 2028 | 9,537 | Acquired |
| Dec. 31, 2018 | TCRT | Stock Option (right to buy) | Common Stock | $1.87 | Dec. 31, 2028 | 126,700 | Acquired |
| Sept. 18, 2018 | TCRT | Stock Option (Right to Buy) | Common Stock | $3.00 | Sept. 18, 2028 | 50,000 | Acquired |
| May 23, 2018 | ESPR | Stock Option (right to buy) | Common Stock | $38.32 | May 23, 2028 | 10,100 | Acquired |
| Jan. 3, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock | $46.35 | Jan. 3, 2028 | 60,000 | Acquired |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 22,000 | Acquired |
| June 2, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.10 | June 2, 2027 | 10,000 | Acquired |
| April 17, 2017 | ESPR | Stock Option (right to buy) | Common Stock | $38.96 | April 17, 2027 | 14,000 | Acquired |
| Dec. 7, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 20,000 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 17,500 | Acquired |
| June 9, 2016 | ESPR | Stock Option (right to buy) | Common Stock | $17.75 | June 9, 2026 | 8,000 | Acquired |
| Aug. 19, 2015 | ESPR | Stock Option (right to buy) | Common Stock | $57.54 | Aug. 19, 2025 | 20,000 | Acquired |
| July 13, 2015 | PCRX | Employee Stock Option (Right to Buy) | Common Stock | $67.11 | July 13, 2025 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 22, 2021 | CRBU | Stock Option (Right to Buy) | 87,440 | Direct |
| June 15, 2015 | ESPR | Common Stock | 52 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $440,462 | $158,010 | $486,200 | $657,872 | · | · | $966 | $1,743,510 |
| 2016 | $419,039 | $134,400 | $352,975 | $680,476 | · | · | $966 | $1,587,856 |
| 2015 | $182,308 | $75,000 | · | $2,502,769 | · | · | $630 | $2,760,707 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.